Concepedia

Author

Hong Zhao

Tianjin Medical UniversityORCID

Also Known As

H Zhao, H. Zhao, Hong Guang Zhao, Hong Zhao

45

Publications

505

Citations

10

H-Index

16

Concepts

All Affiliations

Tianjin Medical UniversityTianjin Medical University Eye HospitalHarbin Medical UniversityNankai University
HZ

About

Hong Zhao is an author at Tianjin Medical University specializing in medicine, cancer research, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

220

2

Pharmacology

2

2

201

3

Anatomy

1

1

19

4

Plastic Surgery

1

1

19

5

Cancer Therapeutics

1

1

10

Hong Zhao

×

9

Publications

390

Citations

9

H-Index

YearCitations

A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

Sharanya Sivanand, Samuel Peña‐Llopis, Hong Zhao,

Science Translational Medicine

2012

191

A retrospective study of 2228 cases with eyelid tumors

Shasha Yu, Yun Zhao, Hong Zhao,

International Journal of Ophthalmology

2018

64

Antiproliferative and Apoptosis-inducing Effect of exo-Protoporphyrin IX based Sonodynamic Therapy on Human Oral Squamous Cell Carcinoma

Yanhong Lv, Jinhua Zheng, Qi Zhou,

Scientific Reports

2017

57

Orbicularis oculi muscle transposition for repairing involutional lower eyelid entropion

Juan Ding, Fengju Chen, Wenjuan Zhai,

Graefe s Archive for Clinical and Experimental Ophthalmology

2014

19

The impact of the COVID-19 outbreak on physical fitness and academic performance of Chinese college students

Hong Zhao, Xiangdong Yang, Fangyu Qu,

Journal of American College Health

2022

16

Comparative evaluation of conventional and modified frontalis muscle flap advancement techniques in the treatment of severe congenital ptosis: A retrospective cohort study

Lei Zhang, Wenjuan Zhai, Lihong Yang,

PLoS ONE

2021

13

Changes in ocular biomechanics after treatment for active Graves’ orbitopathy

Hongxun Li, Xinheng Zhao, Yi Song,

Journal of Endocrinological Investigation

2020

10

228MO PALOMA-4: Primary results from a phase III trial of palbociclib (PAL) + letrozole (LET) vs placebo (PBO) + LET in Asian postmenopausal women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative (ER+/HER2–) advanced breast cancer (ABC)

Bing Xu, Xianglin Hu, W. Li,

Annals of Oncology

2021

10

Pou3f1 mediates the effect of Nfatc3 on ulcerative colitis-associated colorectal cancer by regulating inflammation

Yan Lin, Dongxu Wang, Hong Zhao,

Cellular & Molecular Biology Letters

2022

10

Page 1